1. Home
  2. CMPX vs ATLO Comparison

CMPX vs ATLO Comparison

Compare CMPX & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPX
  • ATLO
  • Stock Information
  • Founded
  • CMPX 2014
  • ATLO 1903
  • Country
  • CMPX United States
  • ATLO United States
  • Employees
  • CMPX N/A
  • ATLO N/A
  • Industry
  • CMPX Biotechnology: Pharmaceutical Preparations
  • ATLO Major Banks
  • Sector
  • CMPX Health Care
  • ATLO Finance
  • Exchange
  • CMPX Nasdaq
  • ATLO Nasdaq
  • Market Cap
  • CMPX 291.8M
  • ATLO 177.0M
  • IPO Year
  • CMPX N/A
  • ATLO N/A
  • Fundamental
  • Price
  • CMPX $3.69
  • ATLO $20.60
  • Analyst Decision
  • CMPX Strong Buy
  • ATLO
  • Analyst Count
  • CMPX 8
  • ATLO 0
  • Target Price
  • CMPX $13.50
  • ATLO N/A
  • AVG Volume (30 Days)
  • CMPX 978.2K
  • ATLO 10.1K
  • Earning Date
  • CMPX 11-11-2025
  • ATLO 11-07-2025
  • Dividend Yield
  • CMPX N/A
  • ATLO 3.89%
  • EPS Growth
  • CMPX N/A
  • ATLO 43.95
  • EPS
  • CMPX N/A
  • ATLO 1.53
  • Revenue
  • CMPX N/A
  • ATLO $57,731,000.00
  • Revenue This Year
  • CMPX N/A
  • ATLO N/A
  • Revenue Next Year
  • CMPX N/A
  • ATLO N/A
  • P/E Ratio
  • CMPX N/A
  • ATLO $13.41
  • Revenue Growth
  • CMPX N/A
  • ATLO 12.59
  • 52 Week Low
  • CMPX $1.27
  • ATLO $15.69
  • 52 Week High
  • CMPX $4.08
  • ATLO $20.75
  • Technical
  • Relative Strength Index (RSI)
  • CMPX 70.81
  • ATLO 67.97
  • Support Level
  • CMPX $3.37
  • ATLO $20.00
  • Resistance Level
  • CMPX $3.70
  • ATLO $20.75
  • Average True Range (ATR)
  • CMPX 0.19
  • ATLO 0.34
  • MACD
  • CMPX 0.03
  • ATLO 0.03
  • Stochastic Oscillator
  • CMPX 96.38
  • ATLO 86.96

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.

Share on Social Networks: